IAM
VIVO

Integre Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Integre Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,802
Closed -$204K – 106
2018
Q2 		$204K Buy
+12,802
New +$191K 0.13% 94
2014
Q1 		– Sell
-28,824
Closed -$765K – 179
2013
Q4 		$765K Buy
28,824
+3,247
+13% +$79.8K 0.17% 91
2013
Q3 		$604K Buy
25,577
+120
+0.5% +$2.8K 0.16% 94
2013
Q2 		$547K Buy
+25,457
New +$549K 0.15% 102

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Integre Asset Management's VIVO Position: Q3 2018 in Review

Integre Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2018, closing a stake of 12,802 shares — an estimated $204K sold.

Integre Asset Management first reported a position in VIVO in Q2 2013 and held it in 4 quarters. The position peaked at $765K in Q4 2013. 177 funds tracked by Wall St. Rank hold VIVO as of Q3 2018.

  • Integre Asset Management reported no remaining Meridian Bioscience Inc position as of Q3 2018 after selling out during the quarter.
  • Integre Asset Management sold 12,802 Meridian Bioscience Inc shares in Q3 2018, an estimated $204K.
  • Integre Asset Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 4 quarters.
  • Integre Asset Management's Meridian Bioscience Inc position peaked at $765K in Q4 2013.
  • 177 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2018.

Based on Integre Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.